0% found this document useful (0 votes)
90 views20 pages

Hematology (MED LAB)

The document discusses hematology tests and their purpose. Hematology involves studying blood and blood-forming organs to evaluate conditions like infection, anemia, and blood disorders. Common hematology tests include full blood counts, which measure red blood cells, white blood cells, platelets, hemoglobin, and other components to assess health and identify issues. Abnormal cell counts could indicate underlying conditions requiring further evaluation. These tests provide important information about a person's health.

Uploaded by

pokwa
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
90 views20 pages

Hematology (MED LAB)

The document discusses hematology tests and their purpose. Hematology involves studying blood and blood-forming organs to evaluate conditions like infection, anemia, and blood disorders. Common hematology tests include full blood counts, which measure red blood cells, white blood cells, platelets, hemoglobin, and other components to assess health and identify issues. Abnormal cell counts could indicate underlying conditions requiring further evaluation. These tests provide important information about a person's health.

Uploaded by

pokwa
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 20

ITEM MARK

1 Introduction
2 Content
3 Summary
4 Reference

TOTAL

KOLEJ KEMAHIRAN TINGGI MARA LEDANG

DIPLOMA IN BIOMEDICAL

ELECTRONICSENGINEERING

APRIL – AUGUST 2021

Medical Laboratory
(DBL 20023)

TOPIC: Hematology

Syafiqah Najihah Binti Ibrahim (DL11951)


NAME / MATRIX Raeisya Marha Binti Pathu Rahman (DL11953)
NO.
Izzah Izzati Binti Abd Hamid (DL11956)

PROGRAM DKL
SESSION APRIL-AUGUST2021
CLASS L4C
LECTURER SIR HAFIDZ BIN HABIZAL

MARKS

1
TABLE OF CONTENT

NO. CONTENT PAGE

1. 1.0 Application of hematology test lab 3

2. 2.0 Meaning of blood cell


4

3. 3.0 Purpose of hematology test

3.1 Full Blood Count Testing 5-17


3.2 White blood cells (Leukocytes – WBCs)
3.3 Platelets (Thrombocytes) test
3.4 Erythrocyte Sedimentation Rate (ESR)
3.5 Clotting Screen TEST

4. 4.0 Haematology Normal Adult Reference


Ranges 17-18

5. 5.0 Discussion
19
6. 6.0 Conclusion
19

7. 7.0 References
20

2
1.0 Application of hematology test lab

Hematology involves the study of the blood, in particular how blood can affect overall health or
disease. Hematology tests include tests on the blood, blood proteins and blood-producing organs.

These tests can evaluate a variety of blood conditions including infection, anemia, inflammation,
hemophilia, blood-clotting disorders, leukemia and the body’s response to chemotherapy
treatments. Tests may be routine and regular, or they may be called upon to diagnose serious
conditions in urgent situations. In many cases, the results of a blood test can give an accurate
assessment of body conditions and how internal or external influences may affect a patient’s health.

The components of human blood include:

Plasma. This is the liquid component of blood in which the following blood cells are suspended.

Red blood cells (erythrocytes). These carry oxygen from the lungs to the rest of the body.

White blood cells (leukocytes). These help fight infections and aid in the immune process. Types of
white blood cells include the following:

Lymphocytes

Monocytes

Eosinophils

Basophils

Neutrophils

Platelets (thrombocytes). These help to control bleeding.

3
2.0 Meaning of blood cell

Blood cells are made in the bone marrow. The bone marrow is the soft, spongy material in the center
of the bones that produces about 95% of the body’s blood cells. Most of the adult body’s bone
marrow is in the pelvic bones, breast bone, and the bones of the spine.

There are other organs and systems in our bodies that help regulate blood cells. The lymph
nodes, spleen, and liver help regulate the production, destruction, and differentiation of cells. The
production and development of new cells is a process called hematopoiesis.

Blood cells formed in the bone marrow start out as a stem cell. A stem cell (or hematopoietic stem
cell) is the initial phase of all blood cells. As the stem cell matures, several distinct cells evolve, such
as the red blood cells, white blood cells, and platelets. Immature blood cells are also called blasts.
Some blasts stay in the marrow to mature and others travel to other parts of the body to develop
into mature, functioning blood cells.

4
3.0 Purpose of hematology test

3.1 Full Blood Count Testing

Full blood count or FBC testing, also known as a complete blood cell count (CBC) is a routine test that
evaluates three major components found in the blood: white blood cells (WBCs), red blood cells
(RBCs) and platelets.

Full blood count or FBC testing is a routine test that evaluates three major components found in
blood: white blood cells, red blood cells and platelets. There are many reasons for a full blood count
test, but common reasons include infection, anemia and suspected haemato-oncological diseases.

A complete blood count test measures several components and features of your blood, including:

 Red blood cells, which carry oxygen

 White blood cells, which fight infection

 Hemoglobin, the oxygen-carrying protein in red blood


cells

 Hematocrit, the proportion of red blood cells to the


fluid component, or plasma, in your blood

 Platelets, which help with blood clotting

Abnormal increases or decreases in cell counts as revealed in a complete blood count may indicate
that you have an underlying medical condition that calls for further evaluation.

FBC testing is pretty simple and takes just a few minutes. A nurse or lab tech will take a sample of
blood by inserting a needle into a vein in your arm.

5
3.1.2 FBC testing measures several components and features of blood, including:

Red blood cells (Erythrocytes – RBCs): the primary function of red blood cells, or erythrocytes, is to
carry oxygen from the lungs to the body tissues, and carbon dioxide as a waste product away from
the tissues and back to the lungs. If your RBC count is too low, you may have anemia or another
condition. The normal range for men is 5 million to 6 million cells/mcL; for women, it’s 4 million to 5
million cells/mcL.

Hemoglobin (Hb): hemoglobin is an important protein in the red blood cells that carries oxygen from
the lungs to all parts of our body. The normal range for men is 14 to 17 grams per deciliter (gm/dL);
for women it’s 12 to 15 gm/dL.

Hematocrit: the proportion of red blood cells to the fluid component, or plasma, in the blood. In
other words, how much of your blood is red blood cells? A low score on the range scale may be a sign
that you have too little iron, the mineral that helps produce red blood cells. A high score could mean
you’re dehydrated or have another condition. The normal range for men is between 41% and 50%.
For women, the range is between 36% and 44%.

Mean corpuscular volume (MCV): this is the average size of your red blood cells. If they’re bigger
than normal, your MCV score goes up. That could indicate low vitamin B12 or folate levels. If your
red blood cells are smaller, you could have a type of anemia e.g. iron deficiency anemia
or thalassemia. A normal-range MCV score is 80 to 95 femtoliters.

Mean corpuscular hemoglobin (MCH): which is the amount of hemoglobin per red blood cell. The
MCH should be 27 to 33 picograms per cell. A low MCH value typically indicates the presence of iron
deficiency anemia. In more rare cases, low MCH can be caused by a genetic condition called
thalassemia. High MCH value can often be caused by anemia due to a deficiency of B vitamins,
particularly B-12 and folate.

Mean corpuscular hemoglobin concentration (MCHC): which is the amount of hemoglobin relative


to the size of the cell or hemoglobin concentration per red blood cell. The MCHC should be 33.4 to
35.5 grams per deciliter. The most common cause of low MCHC is anemia. Hypochromic microcytic
anemia commonly results in low MCHC. This condition means your red blood cells are smaller than
usual and have a decreased level of hemoglobin. When the MCHC is high, the red cells are referred

6
to as being hyperchromic. Possible causes of a high MCHC (which is uncommon) include autoimmune
hemolytic anemia (AIHA), a condition in which the bodies immune system attacks its own red blood
cells and hereditary spherocytosis, a genetic condition characterized by anemia and gallstones.

Reticulocyte Count: The reticulocyte count is the percentage of immature red blood cells
(reticulocytes) in the total red blood cell count (reticulocytes / red blood cells). Reticulocyte Count
Normal Range is 1-2% of the total RBC count.

Red blood cell distribution width (RDW): is a measure of the range of variation of red blood cell
(RBC) volume that is reported as part of a standard complete blood count. Usually, red blood cells
are a standard size of about 6-8 μm in diameter. Certain disorders, however, cause a significant
variation in cell size. Higher RDW values indicate greater variation in size. The normal reference range
of RDW in human red blood cells is 11.5-14.5%. If anemia is observed, RDW test results are often
used together with mean corpuscular volume (MCV) results to determine the possible causes of the
anemia. It is mainly used to differentiate an anemia of mixed causes from an anemia of a single
cause.

Deficiencies of Vitamin B12 or folate produce a macrocytic anemia (large cell anemia) in which the
RDW is elevated in roughly two-thirds of all cases. However, a varied size distribution of red blood
cells is a hallmark of iron deficiency anemia, and as such shows an increased RDW in virtually all
cases. In the case of both iron and B12 deficiencies, there will normally be a mix of both large cells
and small cells, causing the RDW to be elevated. An elevated RDW (red blood cells of unequal sizes)
is known as anisocytosis.

7
An elevation in the RDW is not characteristic of all anemias. Anemia of chronic disease, hereditary
spherocytosis, acute blood loss, aplastic anemia (anemia resulting from an inability of the bone
marrow to produce red blood cells), and certain hereditary hemoglobinopathies (including some
cases of thalassemia minor) may all present with a normal RDW.

3.2 White blood cells (Leukocytes – WBCs):

The primary function of white blood cells, or leukocytes, is to fight infection. They are part of the
immune system. They release special enzymes to help protect your body against foreign invaders.
There are several types of white blood cells and each has its own role in fighting bacterial, viral,
fungal, and parasitic infections.

If you have high WBC levels, it tells your doctor you have inflammation or infection somewhere in
your body. If it’s low, you could be at risk for infection. The normal range is 4,500 to 10,000 cells per
microliter (cells/mcL). Leukocytosis refers to an increase in the total number of white blood cells
(WBCs) due to any cause. From a practical standpoint, leukocytosis is traditionally classified
according to the component of white cells that contribute to an increase in the total number of
WBCs. Therefore, leukocytosis may be caused by an increase in:

3.2.1 (1) Neutrophil count:

Neutrophils are the most plentiful white blood cells, making up 55 to 70 percent of white blood cell
count. The absolute neutrophil count (ANC) ranges between 1.5-8.0 109/l in normal conditions.

Neutrophilia is an increase in circulating neutrophils above that expected in a healthy individual of


the same age, sex, race, and physiological status. This represents an increase in the neutrophil count
above 8.0×109/l and is one of the most frequently observed changes in the FBC. Neutrophils are the
primary white blood cells that respond to a bacterial infection, so the most common cause of
neutrophilia is a bacterial infection, especially pyogenic infections. Neutrophils are also increased in
any acute inflammation, so will be raised after a heart attack, other infarct or burns.

8
On the other hand, Neutropenia is when a person has a low level of neutrophils. Some level of
neutropenia takes place in about half of people with cancer who are receiving chemotherapy. It is a
common side effect in people with leukemia or other conditions that affect the bone marrow
directly, such as lymphoma, multiple myeloma, and myelodysplasia. Radiation therapy to several
parts of the body or to bones in the pelvis, legs, chest, or abdomen can also cause neutropenia. 

Autoimmune neutropenia occurs when an individual’s immune system attacks and destroys


neutrophils. People who have neutropenia should adhere to good personal hygiene to lower their
risk of infection. This includes washing their hands regularly. People who have neutropenia have a
higher risk of getting serious infections. This is because they do not have enough neutrophils to kill
organisms that cause infection.

For patients with neutropenia, even a minor infection can quickly become serious. They should talk
with their health care team right away if they have any of these signs of infection:

 A fever, which is a temperature of 38°C or higher.

 Chills or sweating.

 A sore throat, sores in the mouth, or a toothache.

 Abdominal pain.

 Pain near the anus.

 Pain or burning when urinating, or urinating often.

 Diarrhea or sores around the anus.

9
 A cough or shortness of breath.

 Any redness, swelling, or pain (especially around a cut, wound, or catheter).

 Unusual vaginal discharge or itching.

3.2.2 Lymphocyte count:

Lymphocytosis is an increase in the number of lymphocytes in the blood. In adults, lymphocytosis is


present when the lymphocyte count is greater than 4000 per microliter (4.0×10 9/l), in older children
greater than 7000 per microliter and in infants greater than 9000 per microliter. The three types of
lymphocytes are B lymphocytes, T lymphocytes, and natural killer (NK) cells. All of these cells help
protect the body from infection. Lymphocytes normally represent 20 to 40% of circulating white
blood cells. Lymphocytosis is a feature of infection, particularly in children. In the elderly,
lymphoproliferative disorders, including chronic lymphocytic leukemia and lymphomas, often
present with lymphadenopathy and a lymphocytosis.

On the other hand, lymphocytopenia refers to a count of fewer than 1,000 lymphocytes per


microliter of blood in adults or less than 3,000 lymphocytes per microliter of blood in children. Most
people who have lymphocytopenia have low numbers of T lymphocytes. Sometimes they also have
low numbers of the other types of lymphocytes. Many diseases, conditions, and factors can lead to a
low lymphocyte count. These conditions can be acquired or inherited.

One of the most common acquired causes of lymphocytopenia is AIDS. Inherited causes include
DiGeorge anomaly, Wiskott-Aldrich syndrome, severe combined immunodeficiency syndrome, and
ataxia-telangiectasia. These inherited conditions are rare.

Lymphocytopenia can range from mild to severe. The condition alone may not cause any signs,
symptoms, or serious problems.

How long lymphocytopenia lasts depends on its cause. The treatment for this condition depends on
its cause and severity. Mild lymphocytopenia may not require treatment. If an underlying condition is
successfully treated, lymphocytopenia will likely improve.

If lymphocytopenia causes serious infections, medicines or other treatments are required.

10
3.2.3 Monocyte count:

Monocytes migrate into the tissues where they become macrophages, with specific characteristics
depending on their tissue localization. Monocyte cell count in normal adults is 0.2–1.0×109/l (2–
10%). Monocytosis is defined as an increase in peripheral blood monocytes greater than 1.0×10 9/l. 

The differential diagnosis is broad, as monocytosis is not representative of a specific condition. It is


often a marker of chronic inflammation, either as a result of infection, autoimmune disease or blood
born malignancy.

Common infections causing monocytosis include tuberculosis, subacute bacterial endocarditis,


syphilis, protozoal or rickettsial disease. Common autoimmune diseases in the differential include
SLE, rheumatoid arthritis, sarcoidosis, and inflammatory bowel disease. Malignancy,
especially monocytic leukemia, should always be investigated in a patient with monocytosis and
appropriate symptom features. Monocytosis can also develop during the recovery phase of an acute
infection.

Monocytopenia is a reduction in blood monocyte count to < 0.4×10 9/l. Monocytopenia can increase
the risk of infection, and it can indicate poor prognosis in patients with acetaminophen-induced
hepatic damage and thermal injuries. Peripheral blood monocytopenia does not usually indicate a
decrease in tissue macrophages; in some cases, it can be associated with impaired granuloma
formation in response to infections.

Monocytopenia can result from:

 Chemotherapy-induced myelosuppression (along with other cytopenias).

 Hematopoietic cell mutation involving GATA2.

 Neoplastic disorders (eg, hairy cell leukemia, acute lymphoblastic leukemia, Hodgkin


lymphoma).

 Infections (eg, HIV infection, Epstein-Barr virus infection, adenovirus infection, miliary
tuberculosis).

 Corticosteroid or immunoglobulin therapy.

 Gastric or intestinal resection.

Transient monocytopenia can occur with endotoxemia, hemodialysis, or cyclic neutropenia.

11
3.2.4 Eosinophilic granulocyte count:

Eosinophils are a type of disease-fighting white blood cell. Eosinophilia is defined as a peripheral


blood eosinophil count > 500/μL. Peripheral blood eosinophilia can be caused by numerous allergic,
infectious, and neoplastic disorders, which require a variety of different treatments. A major goal of
the initial evaluation is to identify disorders that require specific treatments (eg, parasitic infection,
drug hypersensitivity, leukemia, non-hematologic cancer). Parasitic diseases and allergic reactions to
medication are among the more common causes of eosinophilia. Eosinophilia that causes organ
damage is called Hypereosinophilic Syndrome. This syndrome tends to have an unknown cause or
results from certain types of cancer, such as bone marrow or lymph node cancer. Treatment is
directed at the cause.

Important considerations in approaching patients with eosinophilia are preexisting diagnoses and
medications (even if started years ago). Mild eosinophilia can commonly be caused by atopic
dermatitis and asthma. However, in patients with eosinophilia over 1500/μL, an alternative diagnosis
should be sought. Asymptomatic eosinophilia in a patient without a history of travel outside of the
US and Europe is unlikely to have an infectious cause.

3.2.5 Basophilic granulocyte count:

Basophils are a type of white blood cell produced in the bone marrow. Normally, basophils make up
less than 1% of your circulating white blood cells.

Basophilia is defined as an elevated absolute basophil count greater than 200 cells/uL or relative
basophil count greater than 2%. The elevation of these cells can often suggest underlying diseases,
such as a myeloproliferative disorder eg, chronic myeloid leukemia or chronic inflammation.

12
A low basophil level is called Basopenia. It can be caused by infections, severe allergies, or an
overactive thyroid gland.

3.2.6 Immature Blood cells: Many people with leukemia have no symptoms at all and are diagnosed
during a routine medical examination. The doctor may find an enlarged lymph node or spleen.
Likewise, the physical examination may be normal but there is an abnormality on a routine complete
blood count (CBC). The CBC may show abnormally high or abnormally low white blood cell counts. In
addition, there may be abnormalities of the red blood cells or platelets. In some cases, there may
be blasts (immature white blood cells) present in the CBC.

Acute Myeloid Leukemia

3.3 Platelets (Thrombocytes)

Platelets also called thrombocytes, are special cell fragments that play an important role in normal
blood clotting. A person who does not have enough platelets may be at an increased risk of excessive
bleeding and bruising. An excess of platelets can cause excessive clotting or if the platelets are not
functioning properly excessive bleeding. The CBC measures the number and size of platelets
present. The normal range is 140,000 to 450,000 cells/mcL.

13
3.4 Erythrocyte Sedimentation Rate (ESR) TEST

Erythrocyte sedimentation rate (ESR or sed rate) is a test that indirectly measures the degree of
inflammation present in the body. The test actually measures the rate of fall (sedimentation) of
erythrocytes (red blood cells) in a sample of blood that has been placed in a tall, thin, vertical tube.
Results are reported as the millimeters of clear fluid (plasma) that are present at the top portion of
the tube after one hour.

When a sample of blood is placed in a tube, the red blood cells normally settle out relatively slowly,
leaving little clear plasma. The red cells settle at a faster rate in the presence of an increased level of
proteins, particularly proteins called acute phase reactants. The level of acute phase reactants such
as C-reactive protein (CRP) and fibrinogen increases in the blood in response to inflammation.

Inflammation is part of the body’s immune response. It can be acute, developing rapidly after
trauma, injury or infection, for example, or can occur over an extended time (chronic) with
conditions such as autoimmune diseases or cancer e.g. multiple myeloma.

14
The ESR is not diagnostic; it is a non-specific test that may be elevated in a number of these different
conditions. It provides general information about the presence or absence of an inflammatory
condition.

There have been questions about the usefulness of the ESR in light of newer tests that have come
into use that are more specific. However, ESR test is typically indicated for the diagnosis and
monitoring of temporal arteritis, systemic vasculitis, and polymyalgia rheumatica. Extremely elevated
ESR is useful in developing a rheumatic disease differential diagnosis. In addition, ESR may still be a
good option in some situations, when, for example, the newer tests are not available in areas with
limited resources or when monitoring the course of a disease.

3.5 Clotting Screen TEST :

When a body tissue is injured and begins to bleed, it initiates a sequence of clotting factor activities
– the coagulation cascade – leading to the formation of a blood clot. This cascade is comprised of
three pathways: extrinsic, intrinsic, and common.

Routine clotting tests comprise of the prothrombin time (PT), fibrinogen, activated partial
thromboplastin time (APTT), thrombin time and D-Dimer. Abnormal clotting results that cannot be
explained in the clinical context should be investigated further by a Specialist Thrombosis and
Haemostasis laboratory.

The clotting screen is a bundled group of tests used pre-operatively to assess bleeding risk and used
to monitor bleeding conditions and some therapies. It tests the PT (and INR), APTT and fibrinogen.

15
3.5.1 Prothrombin Time (PT):

The PT measures the vitamin K dependent clotting pathways (extrinsic pathway) and is therefore of


particular use in measuring the effect of warfarin therapy (warfarin is a vitamin K antagonist). The
vitamin K-dependent coagulation factors are factors II, VII, IX, X (and proteins C, S, and Z). Normal
ranges for the PT vary up and down worldwide depending on the sensitivity of the reagent and the
technology used to determine the clotting times. The INR (international normalized ratio) is a
calculation which is used that takes into account the normal clotting times and the sensitivity of the
reagent used to provide a ratio which is the same worldwide. For example, a PT of 16 seconds in
Leeds and a PT of 33 seconds in London can produce the same INR. The prothrombin time is also
used to determine if there are any deficiency in extrinsic clotting factors and is a useful liver function
test. Raised PTs without cause should be investigated further.

3.5.2 Activated Partial Thromboplastin Time (APTT):

Measures the intrinsic clotting pathway. The intrinsic pathway requires the clotting factors VIII, IX, X,
XI, and XII. Also required are the proteins prekallikrein (PK) and high-molecular-weight kininogen (HK
or HMWK), as well as calcium ions and phospholipids secreted from platelets. APTT is particularly
useful in monitoring heparin therapy. The APTT ratio provides the ratio of APPT : Normal Clotting
time and is the primary calculation used to monitor heparin therapy. The APTT is also useful in
detecting clotting factor deficiencies of the intrinsic pathway and can be raised in the presence
of factor deficiencies and lupus anticoagulants. Raised APTTs without cause should be investigated
further.

* The INR and APTT ratio do not have normal ranges but therapeutic ranges. These are based on
the condition being treated and are decided by the clinical teams.

3.5.3 Thrombin Time (TT):

Is primarily requested by the Liver Disease Units and measures the time it takes for fibrinogen to
form fibrin (one of the later stages of the common clotting pathway). It is also requested by the
laboratories to confirm the presence of heparin contamination of a sample in the event of an
unexplained raised APTT.

3.5.4 Fibrinogen:

The fibrinogen reported routinely is derived from the PT reaction as it occurs. It is primarily a screen.
Any low fibrinogen detected by this method is substituted for the Clauss Fibrinogen test which
measures fibrinogen directly. In DIC (Disseminated Intravascular Coagulation) the derived fibrinogen
may be misleading. Supplying relevant clinical details will ensure the biomedical scientists report the
most appropriate fibrinogen for the clinical situation. The Clauss Fibrinogen can be measured
routinely if asked for on the request card and if DIC is suspected; the Clauss fibrinogen should always
be measured.

16
3.5.5 D-Dimers:

D-dimer is one of the protein fragments produced when a blood clot gets dissolved in the body. It is
normally undetectable or detectable at a very low level unless the body is forming and breaking
down blood clots. Then, its level in the blood can significantly rise. This test detects D-dimer in the
blood.
It is, therefore, a useful predictor of recent clot formation. It is not specific however and can be
affected by many other conditions such as rheumatoid arthritis. It should only be used as a negative
predictor for VTE (venous thromboembolism) i.e. a raised D-Dimer is not diagnostic of a clot
formation, but a normal D-Dimer can be a used as a negative predictor of venous thrombosis. In DIC
the D-Dimer levels are often very high.

4.0 Haematology Normal Adult Reference Ranges

Haematology Normal Adult Reference Ranges Male Female Units

Haemoglobin (HB) 130-180 115-165 g/L

White Cell Count (WBC) 4-11 4-11 109/L

Platelet Count (PLT) 150-450 150-450 109/L

Red Blood Count (RBC) 4.5-6.5 3.8-5.8 1012/L

Mean Cell Volume (MCV) 80-100 80-100 fl

Packed Cell Volume (PCV)/Haematocrit (HCT) 0.40-0.52 0.37-0.47 L/L

Mean Cell Haemoglobin (MCH) 27-32 27-32 pg

Mean Cell Haemoglobin Concentration (MCHC) 320-360 320-360 g/L

Neutrophil Count 2.0-7.5 2.0-7.5 109/L

Lymphocyte Count 1.5-4.5 1.5-4.5 109/L

Monocyte Count 0.2-0.8 0.2-0.8 109/L

Eosinophil Count 0-0.4 0-0.4 109/L

Basophil Count 0-0.1 0-0.1 109/L

Erythrocyte Sedimentation Rate (ESR) 1-10 1-12 mm/hr

Reticulocytes 0.2-2.0 0.2-2.0 %

PT 10.0-13.0 10.0-13.0 Secs

INR 0.8-1.2 0.8-1.2 Ratio

APTT 23-30 23-30 Secs

17
Fibrinogen 1.5-4.5 1.5-4.5 g/L

Antithrombin Activity 80-120 80-120 iu/dL

Protein S Free Antigen 60-140 60-140 iu/dL

Protein C Activity 70-130 70-130 iu/dL

Lupus Anticoagulant <1.2 <1.2 Ratio

Activated Protein C Resistance (APCR) >2.0 >2.0 Ratio

D-Dimers
0.1-0.45 0.1-0.45 mg/L FEU
(this is not the DVT/PE cut-off value)

FDPs <10 <10 ug/mL

Factor VIII 50-150 50-150 iu/dL

Factor IX 50-150 50-150 iu/dL

5.0 Discussion

1. Complete blood count (CBC), which includes:


2. White blood cell count (WBC)
3. Red blood cell count (RBC)
4. Platelet count

18
5. Hematocrit red blood cell volume (HCT)
6. Hemoglobin concentration (HB). This is the oxygen-carrying protein in red blood cells.
7. Differential white blood count
8. Red blood cell indices (measurements)
9. To aid in diagnosing anemia, certain cancers of the blood, inflammatory diseases, and to
monitor blood loss and infection
10. Platelet count (usually done as part of the CBC)
11. Prothrombin time (PT) Partial Thromboplastin Time (PTT) International Normalized Ratio
(INR)

6.0 Conclusion

Hematology is the study of blood and blood disorders. Some explaination of the more common
hematology tests and what purpose they serve. Hematology tests include tests on the blood, blood
proteins and blood-producing organs. Hematological tests can help diagnose anemia, infection,
hemophilia, blood-clotting disorders, and leukemia.

Results in the following areas above or below the normal ranges on a complete blood count may
indicate a problem. For specifics about what your complete blood count results mean if they fall
outside the normal ranges, talk to your doctor.

7.0 REFERENCES

1) (MFMER), F. f. (1998-2021). Complete blood count (CBC). "Mayo Clinic Healthy Living,".

19
2) Dr. Moustafa Abdou (M.B, B., M.Sc, MRCPI, & ASCO, E. a. (November 30, 2018). Common
Hematology Tests. Hematology Tests.

3) royalwolverhampton. (19/05/2017). Haematology Normal Adult Reference Ranges.

4) The Johns Hopkins University, T. J. (2021). HEALTH. Hematology.

20

You might also like